CloudMD Welcomes Mark Kohler as Chairman of the Board

Brings over 30 years’ experience in healthcare, financial services and technology leadership

VANCOUVER, British Columbia, May 14, 2020 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (CSE: DOC, OTCQB: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), a telemedicine company revolutionizing the delivery of healthcare to patients, is pleased to announce its Board of Directors has appointed industry veteran, Mark Kohler as Chairman of the Board.

Mr. Kohler has over 33 years of experience as an entrepreneur, investor, financial executive, and board member at leading healthcare, technology, and financial services organizations in North America. With extensive experience as a C-Level financial executive at both private and publicly listed growth organizations, he is best known as a keen supporter of healthcare technology companies, digital health and virtual care adoption while he has also been focused on M&A, good corporate governance, and shareholder engagement.

He is currently also the Chairman and CEO of Exelerate Capital Corp. (TSXV:XCAP), a well-funded CPC with the mandate to acquire technology businesses, and data privacy and cyber security organizations, that enable the build out of an “Information Supply Chain” for the healthcare sector in North America.

Mr. Kohler is known to be an innovator in his roles with Boards in North America, including as the Executive Chairman at QHR Corporation where he led the Board and management through its profitable and strategic transformation that resulted in the sale of the company to Loblaw Companies Limited for approx. $170 million. He was also the Chairman of the Board for Community Trust, one of Canada’s leading OSFI - federally regulated Trust Companies (since sold to Questrade), where he led the design of the Bank’s Enterprise Risk Management Framework, and the adoption of its leading Corporate Governance practices. Most recently, he was the Audit Committee Chairman at Versapay Corporation, which was sold at a significant gain to a U.S. based private equity fund in February 2020, for approximately $126 million.

He is also an avid supporter of not-for-profit activities, which includes being a Member of the World Health Innovation Network (“WIN”), and a Health-Leader in Residence at this non-profit collaborative that focuses on sourcing innovative and scalable technology models that enhance delivery of care and supply chains in health systems, around the world.